The proposed rule amendments are intended to address changes to the PA formulary pursuant to recent legislation.  


  • RULE NO: RULE TITLE
    64B8-30.008: Formulary
    PURPOSE AND EFFECT: The proposed rule amendments are intended to address changes to the PA formulary pursuant to recent legislation.
    SUMMARY: The proposed rule amendment deletes antipsychotics and parenteral preparations from the list of prohibited drugs which can be prescribed by physician assistants.
    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: A Statement of Estimated Regulatory Cost has been prepared and is available by contacting: Larry McPherson, Jr., Executive Director, at the address listed below.
    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
    SPECIFIC AUTHORITY: 458.309, 458.347(4)(f)1. FS.
    LAW IMPLEMENTED: 458.347(4)(e), (f) FS.
    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Larry McPherson, Jr., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

    THE FULL TEXT OF THE PROPOSED RULE IS:

    64B8-30.008 Formulary.

    (1) PHYSICIAN ASSISTANTS APPROVED TO PRESCRIBE MEDICINAL DRUGS UNDER THE PROVISIONS OF SECTION 458.347(4)(e) OR 459.022(4)(e), F.S., ARE NOT AUTHORIZED TO PRESCRIBE THE FOLLOWING MEDICINAL DRUGS, IN PURE FORM OR COMBINATION:

    (a) Controlled substances, as defined in Chapter 893, F.S.

    (b) Antipsychotics.

    (b)(c) General, spinal or epidural anesthetics.

    (c)(d) Radiographic contrast materials.

    (e) Any parenteral preparation except insulin and epinephrine. Parenteral includes: intravenous, subcutaneous, intramuscular, and any route other than the alimentary canal; however, it does not include topical or mucosal application. Nothing in this formulary prohibits a physician assistant from administering a parenteral drug under the direction or supervision of the supervising physician.

    (2) through (4) No change.

    Rulemaking Specific Authority 458.309, 458.347(4)(f)1. FS. Law Implemented 458.347(4)(e), (f) FS. History–New 3-12-94, Formerly 61F6-17.0038, Amended 11-30-94, 2-22-95, 1-24-96, 11-13-96, 3-26-97, Formerly 59R-30.008, Amended 11-26-97, 1-11-99, 12-28-99, 6-20-00, 11-13-00, 2-15-02, 7-30-03, ________.


    NAME OF PERSON ORIGINATING PROPOSED RULE: Council on Physician Assistants
    NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Medicine
    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: February 7, 2009
    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAW: October 10, 2008

Document Information

Comments Open:
4/17/2009
Summary:
The proposed rule amendment deletes antipsychotics and parenteral preparations from the list of prohibited drugs which can be prescribed by physician assistants.
Purpose:
The proposed rule amendments are intended to address changes to the PA formulary pursuant to recent legislation.
Rulemaking Authority:
458.309, 458.347(4)(f)1. FS.
Law:
458.347(4)(e), (f) FS.
Contact:
Larry McPherson, Jr., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253
Related Rules: (1)
64B8-30.008. Formulary